Meningococcal Disease Alert in Western Australia: A Timely Reminder
Meningococcal disease is a rare but deadly infection that demands our attention. The Western Australian Health Department has identified four new cases of this bacterial menace, with two patients diagnosed in December 2025 and another two in January 2026. But here's the crucial part: these cases are unrelated.
Meningococcal disease is a stealthy invader, causing severe illness by infecting the blood, spinal cord, and brain membranes. It can also affect the throat, lungs, and joints. In 2025, Western Australia recorded 13 cases of this invasive disease, including one tragic death, mirroring the statistics from 2024. Among these cases, 12 were attributed to serogroup B, while one was serogroup Y.
These recent cases don't signal a surge in meningococcal infections, but health authorities remain vigilant. The disease is not easily transmitted between people; the bacteria are found in respiratory droplets from coughing or sneezing but don't survive long outside the body. Interestingly, 10-20% of people unknowingly carry these bacteria in their nose and throat without any harm.
However, when the bacteria turn invasive, the consequences can be dire. Symptoms include high fever, chills, severe headaches, neck stiffness, nausea, vomiting, confusion, and intense muscle and joint pain. In some cases, a distinctive red-purple rash may appear, resembling tiny bleeding spots under the skin.
Young children may not express their symptoms verbally, so parents should watch for signs like fever, pale or blotchy skin, vomiting, lethargy, poor feeding, and rash. Timely treatment with antibiotics is crucial, as the disease can progress rapidly. While most patients recover, the disease can be fatal in 5-10% of cases, and 15% may suffer long-term complications such as hearing loss, limb amputation, or brain damage.
Vaccination is a powerful defense against this disease. Western Australia offers two types of meningococcal vaccines: one targeting serogroups A, C, W, and Y, and another specifically for serogroup B. The MenACWY vaccine is provided free to all 12-month-old children and Year 10 students, with a catch-up program for adolescents aged 15-19. Aboriginal children receive special consideration, with free MenACWY vaccines for those aged 6 weeks to 12 months and free MenB vaccines for those up to 2 years old.
The vaccines are also available free of charge to individuals with certain medical risk factors, and others can access them through their healthcare providers. For more information on this critical health issue, visit Healthy WA (https://www.healthywa.wa.gov.au/Articles/J_M/Meningococcal-disease). Stay informed, stay protected!
